Candesartan cilexetil as a repurposed therapeutic candidate for nasopharyngeal carcinoma: Integrated in vitro and in silico analyses
Year: 2025
Type: article
Abstract: analyses highlights CC as a promising repurposed therapeutic candidate for NPC and supports further preclinical evaluation. See also the graphical abstract(Fig. 1).
Source: EXCLI journal
Language: English
Subfield: Computational Theory and Mathematics
Field: Computer Science
Domain: Physical Sciences
Open Access status: diamond
OpenAlex ID: W7124423944
